Skip to main content
Top
Published in: Trials 1/2016

Open Access 01-12-2016 | Study protocol

NETS1HD: study protocol for development of a core outcome set for use in determining the overall success of Hirschsprung’s disease treatment

Authors: Benjamin Allin, Timothy Bradnock, Simon Kenny, Gregor Walker, Marian Knight

Published in: Trials | Issue 1/2016

Login to get access

Abstract

Background

Use of core outcome sets in research has been proposed as a method for countering the problems caused by heterogeneity of outcome measure reporting. Heterogeneity of outcome measure reporting occurs in Hirschsprung’s disease (HD) research and is limiting the development of a robust evidence base to support clinical practice.

Methods

Candidate outcome measures have been identified through a systematic review. These outcome measures will form the starting point for a three-phase online Delphi process to be carried out in parallel by three panels of experts. Panel 1 is a neonatal panel; panel 2 is a non-neonatal panel; and panel 3 is a lay panel. In round 1, experts will be asked to score the previously identified outcome measures from 1 to 9 based on how important they think the measures are in determining the overall success of their/their child’s/their patient’s HD. In round 2, experts will be presented with the same list of outcome measures and graphical representations of how their panel scored that outcome in round 1. They will be asked to re-score the outcome measure, taking into account how important other members of their panel felt it to be. In round 3, experts will again be asked to re-score each outcome measure, but this time they will receive a graphical representation of the distribution of scores from all three panels, which they should take into account when re-scoring. Following round 3 of the Delphi process, 40 experts will be invited to attend a face-to-face consensus meeting. Participants will be invited in a purposive manner to obtain balance between the different panels. Results of the Delphi process will be discussed, and outcomes will be re-scored. Outcome measures where >70% of participants at the meeting scored it 7–9 and <15% scored it 1–3 will form the core outcome set.

Discussion

Development of a core outcome set will help to reduce heterogeneity of outcome measure reporting in HD. This will increase the quality of research taking place and ultimately improve care provided to infants with HD.
Appendix
Available only for authorised users
Literature
1.
go back to reference De la Torre-Mondragón L, Ortega-Salgado JA. Transanal endorectal pull-through for Hirschsprung’s disease. J Pediatr Surg. 1998;33(8):1283–6.CrossRefPubMed De la Torre-Mondragón L, Ortega-Salgado JA. Transanal endorectal pull-through for Hirschsprung’s disease. J Pediatr Surg. 1998;33(8):1283–6.CrossRefPubMed
2.
go back to reference Georgeson KE, Fuenfer MM, Hardin WD. Primary laparoscopic pull-through for Hirschsprung’s disease in infants and children. J Pediatr Surg. 1995;30(7):1017–22.CrossRefPubMed Georgeson KE, Fuenfer MM, Hardin WD. Primary laparoscopic pull-through for Hirschsprung’s disease in infants and children. J Pediatr Surg. 1995;30(7):1017–22.CrossRefPubMed
4.
go back to reference Swenson O, Bill Jr AH. Resection of rectum and rectosigmoid with preservation of the sphincter for benign spastic lesions producing megacolon; an experimental study. Surgery. 1948;24(2):212–20.PubMed Swenson O, Bill Jr AH. Resection of rectum and rectosigmoid with preservation of the sphincter for benign spastic lesions producing megacolon; an experimental study. Surgery. 1948;24(2):212–20.PubMed
6.
go back to reference Chen Y, Nah SA, Laksmi NK, Ong CC, Chua JH, Jacobsen A, et al. Transanal endorectal pull-through versus transabdominal approach for Hirschsprung’s disease: a systematic review and meta-analysis. J Pediatr Surg. 2013;48(3):642–51.CrossRefPubMed Chen Y, Nah SA, Laksmi NK, Ong CC, Chua JH, Jacobsen A, et al. Transanal endorectal pull-through versus transabdominal approach for Hirschsprung’s disease: a systematic review and meta-analysis. J Pediatr Surg. 2013;48(3):642–51.CrossRefPubMed
7.
go back to reference Thomson D, Allin B, Long AM, Bradnock T, Walker G, Knight M. Laparoscopic assistance for primary transanal pull-through in Hirschsprung’s disease: a systematic review and meta-analysis. BMJ Open. 2015;5(3), e006063.CrossRefPubMedPubMedCentral Thomson D, Allin B, Long AM, Bradnock T, Walker G, Knight M. Laparoscopic assistance for primary transanal pull-through in Hirschsprung’s disease: a systematic review and meta-analysis. BMJ Open. 2015;5(3), e006063.CrossRefPubMedPubMedCentral
8.
go back to reference Williamson P, Altman D, Blazeby J, Clarke M, Gargon E. Driving up the quality and relevance of research through the use of agreed core outcomes. J Health Serv Res Policy. 2012;17(1):1–2.CrossRefPubMed Williamson P, Altman D, Blazeby J, Clarke M, Gargon E. Driving up the quality and relevance of research through the use of agreed core outcomes. J Health Serv Res Policy. 2012;17(1):1–2.CrossRefPubMed
9.
go back to reference Williamson P, Altman D, Blazeby J, Clarke M, Gargon E. The COMET (Core Outcome Measures in Effectiveness Trials) Initiative. Trials. 2011;12 Suppl 1:A70.CrossRefPubMedCentral Williamson P, Altman D, Blazeby J, Clarke M, Gargon E. The COMET (Core Outcome Measures in Effectiveness Trials) Initiative. Trials. 2011;12 Suppl 1:A70.CrossRefPubMedCentral
10.
go back to reference Bautista-Molano W, Navarro-Compán V, Landewé RM, Boers M, Kirkham J, van der Heijde D. How well are the ASAS/OMERACT Core Outcome Sets for Ankylosing Spondylitis implemented in randomized clinical trials? A systematic literature review. Clin Rheumatol. 2014;33(9):1313–22.CrossRefPubMed Bautista-Molano W, Navarro-Compán V, Landewé RM, Boers M, Kirkham J, van der Heijde D. How well are the ASAS/OMERACT Core Outcome Sets for Ankylosing Spondylitis implemented in randomized clinical trials? A systematic literature review. Clin Rheumatol. 2014;33(9):1313–22.CrossRefPubMed
11.
go back to reference Allin B, Aveyard N, Campion-Smith T, Floyd E, Kimpton J, Swarbrick K, et al. What evidence underlies clinical practice in paediatric surgery? A systematic review assessing choice of study design. PLoS One. 2016;11(3), e0150864.CrossRefPubMedPubMedCentral Allin B, Aveyard N, Campion-Smith T, Floyd E, Kimpton J, Swarbrick K, et al. What evidence underlies clinical practice in paediatric surgery? A systematic review assessing choice of study design. PLoS One. 2016;11(3), e0150864.CrossRefPubMedPubMedCentral
12.
go back to reference Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, et al. Developing core outcome sets for clinical trials: issues to consider. Trials. 2012;13:132.CrossRefPubMedPubMedCentral Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, et al. Developing core outcome sets for clinical trials: issues to consider. Trials. 2012;13:132.CrossRefPubMedPubMedCentral
13.
go back to reference Harman N, Bruce I, Callery P, Tierney S, Sharif MO, O’Brien K, et al. MOMENT - Management of Otitis Media with Effusion in Cleft Palate: protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey. Trials. 2013;14:70.CrossRefPubMedPubMedCentral Harman N, Bruce I, Callery P, Tierney S, Sharif MO, O’Brien K, et al. MOMENT - Management of Otitis Media with Effusion in Cleft Palate: protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey. Trials. 2013;14:70.CrossRefPubMedPubMedCentral
Metadata
Title
NETS1HD: study protocol for development of a core outcome set for use in determining the overall success of Hirschsprung’s disease treatment
Authors
Benjamin Allin
Timothy Bradnock
Simon Kenny
Gregor Walker
Marian Knight
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Trials / Issue 1/2016
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-016-1693-6

Other articles of this Issue 1/2016

Trials 1/2016 Go to the issue